What Is Cytotoxic Drug Manufacturing? Cytotoxic drug manufacturing is a specialized area of pharmaceutical production focused on the safe handling, formulation, and fill-finish of compounds that are toxic…
Why Blow Fill Seal Technology Is Growing in Pharmaceutical Manufacturing Blow fill seal technology is one of the fastest-growing segments in sterile pharmaceutical manufacturing. A single continuous automated process forms,…
What Is an Isolator Filling Workcell? An isolator filling workcell is a robotic, closed-system aseptic filling platform designed to eliminate human presence from the critical fill…
BioCina Initiates Comprehensive Manufacturing Program for Patrys’ Proprietary Injectable Therapeutic to Alleviate Delirium BioCina Pty Ltd., announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the advancement of RLS-2201.…
BioCina Attending Biotech Showcase During JPM Week We’re excited to announce that the BioCina team will be attending Biotech Showcase during JPM Week!…
Agility in Biomanufacturing: The Key to Overcoming Uncertainty In today’s biopharma landscape, resilience isn’t enough — CDMOs must also be agile. Agility enables clients to adjust quickly to…
BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dr. Thomas Broudy has been appointed as…
What’s next for mRNA after COVID-19? The pandemic proved that mRNA-based vaccines could be developed, manufactured, and distributed globally in record time. But the real promise…
Expanding LNP Applications Beyond mRNA Vaccines Lipid nanoparticles (LNPs) have transformed how we deliver mRNA. But their role in modern medicine is just beginning. In this…